PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,579,285 | +277.8% | 53,247 | +197.7% | 1.32% | +378.3% |
Q4 2022 | $682,709 | -31.6% | 17,886 | -9.1% | 0.28% | +403.6% |
Q2 2020 | $998,000 | +56.9% | 19,677 | +16.4% | 0.06% | -78.1% |
Q1 2019 | $636,000 | +32.5% | 16,903 | +14.2% | 0.25% | +55.9% |
Q4 2015 | $480,000 | -21.8% | 14,800 | -35.7% | 0.16% | -21.5% |
Q3 2015 | $614,000 | -47.1% | 23,000 | -4.6% | 0.20% | -40.1% |
Q2 2015 | $1,160,000 | – | 24,100 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |